AM Pharma

Developing treatments for severe medical conditions

Utrecht, Netherlands · Founded 2001 · $239.1M raised

Headquarters
Utrecht
Employees
11–50
Founded
2001
Business Model
B2B
Total Funding
$239.1M
Last Round
$52.0M Extension RoundMar 2020
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

AM-Pharma is a Dutch clinical-stage biopharmaceutical company developing recombinant alkaline phosphatase (recAP) therapies for inflammatory conditions including acute kidney injury (AKI) and sepsis. Founded in 2001 and headquartered in Bunnik, Netherlands, the company is advancing its lead candidate BIIB1079 through late-stage clinical trials in collaboration with Biogen.

Summary

AM Pharma is a Biotech company based in Utrecht, Netherlands, founded in 2001. It has raised $239.1M in total across 6 rounds, most recently a $52.0M Extension Round in Mar 2020.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundMar 2020
$52.0M

Sign up to see all 6 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AM Pharma on Indexed.vc
<a href="https://indexed.vc/companies/am-pharma"><img src="https://indexed.vc/api/badge/company/am-pharma" alt="AM Pharma on Indexed.vc" width="260" height="76" /></a>